Sam68 was found overexpressed and associated with poor prognosis in several cancer types, including non-small cell lung carcinoma and breast, hepatocellular, renal, prostate and gastric cancers (Busa et al., 2007; Zhang et al., 2009, 2014, 2015; Song et al., 2010; Xiao et al., 2018). Here, KHDRBS1 is linked to cancer.